Cuorips

IPO

Cuorips Inc. | Pioneering the Future of Cell Therapeutics

Public · Osaka, Japan · Founded 2017 · $19.3M raised

Headquarters
Osaka
Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$19.3M
Last Round
$19.3M Venture RoundDec 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cuorips Inc. is a Japan-based cell-therapeutics company whose name combines the Italian word for heart with 'iPS' (induced pluripotent stem) cells. Founded March 21, 2017 and headquartered in Osaka, Cuorips develops iPSC-derived cell therapies including RiHEART, a pioneering cardiac patch, alongside catheter-delivered therapies and small-molecule programs, using its VMaCS platform to mass-manufacture and deliver cell therapies globally.

Summary

Cuorips is a Biotech company based in Osaka, Japan, founded in 2017. It has raised $19.3M in total across 1 round, most recently a $19.3M Venture Round in Dec 2020. Investors include JIC Venture Growth Investments, Kyoto University Innovation Capital and Jafco Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJun 2023

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cuorips on Indexed.vc
<a href="https://indexed.vc/companies/cuorips"><img src="https://indexed.vc/api/badge/company/cuorips" alt="Cuorips on Indexed.vc" width="260" height="76" /></a>